From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver Pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and business process infrastructure for market access and therapy commercialization.
Solutions overview
IntegriChain delivers pharma’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the pharmaceutical industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
May 29, 2019 | 1 pm ET
Please join us for the first session of our webinar series exploring the benefits, trends and winning strategies for Gross-to-Net Automation. We begin this series by reiterating best practices and exploring modern options for automating and optimizing channel distribution datasets when setting pipeline and returns accruals as part of the broader gross-to-net process.
Jennifer Sharpe, Executive Advisor, Revenue Analytics Collaborative Melissa O’Neal, Executive Director, Product Management – Distribution Shivani Patel, Solutions Principal, Industry Solutions
During the webinar, we’ll explore the challenges Life Sciences manufacturers face when incorporating returns and pipeline inventory data into the GTN process. We’ll take a deep dive, examining how manufacturers can reduce potential misstatements of returns and pipeline liabilities due to the lack of triangulation with other channel and commercial data sets.
We’ll also review the different ways manufacturers are dealing with pipeline and returns data in their GTN process today including leading-edge automated GTN processes.
Then, we’ll walk through best practices for incorporating returns and retail data into a GTN process, including: